This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Dec 1, 2017Quest Diagnostics Completes Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration with Cleveland ClinicCleveland HeartLab's Laboratory Facility is Now Quest's National Cardiometabolic Center of Excellence, Serving Physicians and Patients Seeking to Identify and Address Hidden Risks of Heart Disease
Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of Cleveland HeartLab. Quest will establish a national center of excellence focused on...
Nov 29, 2017
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
Nov 20, 2017Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided an update on the impact of the Centers for Medicare and Medicaid Services (CMS)...
Nov 13, 2017At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programs
Bridgewater, N.J., and Secaucus, N.J., Nov. 13, 2017 -- Clinical Genomics, a private company and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,...
Nov 1, 2017Quest Diagnostics to Present New Insights in Autoimmune Disease at the 2017 American College of Rheumatology MeetingFive Presentations Show the Clinical Value of Diagnostic Innovations for Assessing Prevalent Autoimmune Diseases, Including Rheumatoid Arthritis and Lupus
Secaucus, NJ, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that it will present results of...